Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

@article{Vos2016GlobalRA,
  title={Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015},
  author={T. Vos and Christine Allen and Megha Arora and Ryan M. Barber and Z. Bhutta and Alexandria Brown and Austin Carter and Daniel C. Casey and F. Charlson and A. Chen and Megan S Coggeshall and Leslie Cornaby and L. Dandona and D. Dicker and Tina Dilegge and H. Erskine and A. Ferrari and C. Fitzmaurice and T. Fleming and M. Forouzanfar and N. Fullman and P. Gething and Ellen M. Goldberg and Nicholas Graetz and J. Haagsma and C. Johnson and N. Kassebaum and T. Kawashima and L. Kemmer and I. Khalil and Y. Kinfu and Hmwe H. Kyu and J. Leung and Xiaofeng Liang and Stephen S. Lim and Alan D. Lopez and R. Lozano and L. Marczak and G. Mensah and A. Mokdad and M. Naghavi and Grant Nguyen and E. Nsoesie and H. Olsen and D. Pigott and Christine Pinho and Zane Rankin and Nikolas Reinig and J. Salomon and Logan Sandar and Alison Smith and J. Stanaway and C. Steiner and Stephanie Teeple and Bernadette A. Thomas and C. Troeger and J. Wagner and Haidong Wang and Valentine Wanga and H. Whiteford and Leo Zoeckler and A. Abajobir and K. H. Abate and C. Abbafati and K. Abbas and F. Abd-allah and Biju Abraham and I. Abubakar and L. Abu-Raddad and N. Abu-Rmeileh and I. Ackerman and A. Adebiyi and Z. Ademi and A. K. Adou and K. Afanvi and E. Agardh and A. Agarwal and A. Kiadaliri and H. Ahmadieh and O. Ajala and R. Akinyemi and N. Akseer and Z. Al-Aly and K. Alam and Noore K M Alam and S. Aldhahri and M. Alegretti and Z. A. Alemu and Lily T Alexander and Samia Alhabib and R. Ali and A. Alkerwi and F. Alla and P. Allebeck and R. Al-Raddadi and U. Alsharif and K. Altirkawi and N. Alvis-Guzm{\'a}n and A. Amare and A. Amberbir and H. Amini and W. Ammar and S. Amrock and H. H. Andersen and G. M. Anderson and B. Anderson and C. A. Antonio and A. Aregay and J. {\"A}rnl{\"o}v and A. Artaman and H. Asayesh and R. Assadi and S. Atique and Euripide Avokpaho and A. Awasthi and B. Quintanilla and P. Azzopardi and U. Bacha and A. Badawi and K. Balakrishnan and A. Banerjee and A. Barac and S. Barker-Collo and T. B{\"a}rnighausen and L. Barregard and L. Barrero and A. Basu and S. Bazargan-Hejazi and Brent Bell and M. Bell and D. Bennett and I. Bense{\~n}or and H. Benzian and A. Berhane and E. Bernab{\'e} and B. Betsu and A. S. Beyene and N. Bhala and S. Bhatt and S. Biadgilign and Kelly Bienhoff and B. Bikbov and S. Biryukov and D. Bisanzio and E. Bjertness and J. Blore and R. Borschmann and S. Boufous and M. Brainin and A. Brazinova and N. Breitborde and Jonathan C. Brown and R. Buchbinder and G. Buckle and Z. Butt and B. Calabria and I. Campos-Nonato and J. Campuzano and H. Carabin and Rosario C{\'a}rdenas and D. Carpenter and J. Carrero and C. Casta{\~n}eda-Orjuela and Jacqueline Castillo Rivas and F. Catal{\'a}-L{\'o}pez and Jung-chen Chang and P. Chiang and C. Chibueze and V. Chisumpa and J. Choi and R. Chowdhury and H. Christensen and D. Christopher and L. Ciobanu and M. Cirillo and M. Coates and Samantha M. Colquhoun and C. Cooper and M. Cortinovis and J. Crump and S. Damtew and R. Dandona and Farah Daoud and P. Dargan and J. das Neves and G. Davey and A. Davis and D. Leo and L. Degenhardt and L. Gobbo and R. Dellavalle and K. Deribe and A. Deribew and S. Derrett and D. D. Jarlais and S. Dharmaratne and P. Dhillon and C. D{\'i}az-Torn{\'e} and E. Ding and T. Driscoll and L. Duan and M. Dubey and B. Duncan and H. Ebrahimi and R. Ellenbogen and I. Elyazar and M. Endres and A. Endries and S. P. Ermakov and B. Eshrati and Kara Estep and T. Farid and C. Farinha and A. Faro and M. Farvid and F. Farzadfar and V. Feigin and D. Felson and S. Fereshtehnejad and J. Fernandes and F. Fischer and J. Fitchett and Kyle Foreman and F. Fowkes and Jordan Fox and R. Franklin and J. Friedman and J. Frostad and Thomas F{\"u}rst and N. Futran and B. Gabbe and P. Ganguly and F. Gankp{\'e} and T. Gebre and T. Gebrehiwot and A. Gebremedhin and J. Geleijnse and B. Gessner and K. Gibney and I. Ginawi and A. Z. Giref and M. Giroud and Melkamu Dedefo Gishu and E. Glaser and W. Godwin and H. G{\'o}mez-Dant{\'e}s and Philimon N. Gona and A. Goodridge and S. Gopalani and C. Gotay and A. Goto and H. Gouda and R. Grainger and F. Greaves and F. Guillemin and Yuming Guo and Rahul Gupta and Rajeev Gupta and Vipin Gupta and R. A. Guti{\'e}rrez and D. Haile and A. Hailu and G. B. Hailu and Y. Halasa and R. Hamadeh and S. Hamidi and M. Hammami and Jamie Hancock and A. Handal and G. Hankey and Y. Hao and H. Harb and S. Harikrishnan and J. Haro and Rasmus J Havmoeller and R. Hay and I. Heredia-Pi and P. Heydarpour and H. Hoek and M. Horino and N. Horita and H. Hosgood and D. Hoy and Aung Soe Htet and Hsiang Huang and John J Emmanuel Huang and Chantal K Huynh and Marissa L Iannarone and K. Iburg and K. Innos and M. Inoue and V. Iyer and K. Jacobsen and N. Jahanmehr and M. Jakovljevic and M. Javanbakht and A. Jayatilleke and S. Jee and P. Jeemon and Paul N Jensen and Y. Jiang and T. Jibat and A. Jim{\'e}nez‐Corona and Ye Jin and J. Jonas and Z. Kabir and Y. Kalkonde and R. Kamal and H. Kan and A. Karch and C. Karema and C. Karimkhani and A. Kasaeian and Anil Kaul and N. Kawakami and P. Keiyoro and A. Kemp and A. Keren and C. Kesavachandran and Y. Khader and Abdur Rahman Khan and E. Khan and Y. Khang and Sahil Khera and T. Khoja and J. Khubchandani and C. Kieling and Pauline Kim and Cho-il Kim and Daniel Kim and Y. Kim and N. Kissoon and L. Knibbs and A. Knudsen and Y. Kokubo and D. Kolte and J. Kopec and S. Kosen and G. Kotsakis and P. Koul and A. Koyanagi and Michael A Kravchenko and B. K. Defo and B. K. Bicer and A. Kudom and E. Kuipers and G. A. Kumar and Michael Kutz and G. Kwan and A. Lal and R. Lalloo and T. Lallukka and H. Lam and J. Lam and S. Langan and A. Larsson and P. Lavados and J. Leasher and J. Leigh and R. Leung and M. Levi and Yichong Li and Yongmei Li and Juan Liang and Shiwei Liu and Y. Liu and B. Lloyd and W. Lo and G. Logroscino and K. Looker and P. Lotufo and R. Lunevicius and R. Lyons and M. Mackay and Mohammed Magdy and A. Razek and M. Mahdavi and M. Majdan and A. Majeed and R. Malekzadeh and W. Marcenes and D. Margolis and J. Martinez-Raga and F. Masiye and J. Massano and S. Mcgarvey and J. McGrath and M. Mckee and B. McMahon and P. Meaney and A. Mehari and Fabiola Mej{\'i}a-Rodr{\'i}guez and A. Mekonnen and Y. Melaku and P. Memiah and Z. Memish and W. Mendoza and A. Meretoja and T. Meretoja and F. Mhimbira and T. Miller and E. Mills and M. Mirarefin and P. Mitchell and C. Mock and A. Mohammadi and S. Mohammed and L. Monasta and J. C. M. Hernandez and M. Montico and M. Mooney and M. Moradi-Lakeh and L. Morawska and U. Mueller and Erin C Mullany and J. Mumford and M. Murdoch and J. Nachega and G. Nagel and A. Naheed and L. Naldi and V. Nangia and J. Newton and Marie Ng and F. Ngalesoni and Q. Nguyen and M. Nisar and P. M. N. Pete and J. Nolla and O. Norheim and R. Norman and B. Norrving and B. P. Nunes and F. Ogbo and I. Oh and T. Ohkubo and Pedro R Olivares and B. Olusanya and J. Olusanya and Alberto Ortiz and Majdi Osman and E. Ota and Mahesh Pa and Eun-Kee Park and M. Parsaeian and Val{\'e}ria Maria de Azeredo Passos and A. P. Caicedo and S. Patten and G. Patton and David M Pereira and R. Perez-Padilla and N. Perico and K. Pesudovs and M. Petzold and M. Phillips and F. Piel and J. Pillay and F. Pishgar and D. Plass and J. Platts-Mills and S. Polinder and C. Pond and S. Popova and R. Poulton and F. Pourmalek and D. Prabhakaran and N. Prasad and M. Qorbani and Rynaz H S Rabiee and A. Radfar and Anwar Rafay and K. Rahimi and V. Rahimi-Movaghar and M. Rahman and Mohammad Hifz Ur Rahman and S. Rahman and R. Rai and S. Raj{\vs}i{\'c} and U. Ram and P. Rao and A. Refaat and M. Reitsma and G. Remuzzi and S. Resnikoff and A. E. Reynolds and A. Ribeiro and M. Blancas and H. S. Roba and D. Rojas-Rueda and L. Ronfani and G. Roshandel and Gregory A. Roth and D. Rothenbacher and Ambuj Roy and R. Sagar and R. Sahathevan and J. Sanabria and M. S{\'a}nchez-Ni{\~n}o and I. Santos and J. Santos and R. Sarmiento-Su{\'a}rez and B. Sartorius and Maheswar Satpathy and M. Savic and M. Sawhney and M. Schaub and Maria In{\^e}s Schmidt and I. Schneider and B. Sch{\"o}ttker and D. Schwebel and James G. Scott and S. Seedat and S. Sepanlou and E. Serv{\'a}n-Mori and K. Shackelford and A. Shaheen and M. Shaikh and Rajesh Sharma and U. Sharma and Jiabin Shen and D. Shepard and K. Sheth and K. Shibuya and Min-Jeong Shin and R. Shiri and I. Shiue and M. Shrime and I. Sigfusdottir and D. Silva and D. Silveira and Ashutosh Kumar Singh and J. Singh and O. Singh and P. Singh and Anna Sivonda and V. Skirbekk and J. Skogen and Amber Sligar and K. Sliwa and M. Soljak and K. S{\o}reide and J. Soriano and L. Sposato and C. Sreeramareddy and V. Stathopoulou and N. Steel and Dan J Stein and T. Steiner and Sabine I. B. Steinke and L. Stovner and K. Stroumpoulis and B. Sunguya and P. Sur and S. Swaminathan and Bryan L. Sykes and C. Szoeke and R. Tabar{\'e}s-Seisdedos and J. Takala and N. Tandon and D. Tann{\'e} and M. Tavakkoli and B. Taye and H. Taylor and B. Ao and B. Tedla and A. Terkawi and A. Thomson and A. Thorne-Lyman and A. Thrift and G. Thurston and Ruoyan Tobe-Gai and M. Tonelli and R. Topor-Madry and F. Topouzis and B. Tran and Z. T. Dimbuene and M. Tsilimbaris and A. K. Tura and E. Tuzcu and S. Tyrovolas and K. Ukwaja and E. Undurraga and C. Uneke and O. Uthman and C. V. van Gool and Yuri Y Varakin and T. Vasankari and N. Venketasubramanian and R. Verma and F. Violante and S. Vladimirov and V. Vlassov and S. Vollset and G. Wagner and S. Waller and Linhong Wang and D. Watkins and S. Weichenthal and E. Weiderpass and R. Weintraub and A. Werdecker and R. Westerman and Richard A. White and H. Williams and C. Wiysonge and C. Wolfe and S. Won and Rachel Woodbrook and M. Wubshet and D. Xavier and Gelin Xu and A. Yadav and Lijing L. Yan and Y. Yano and M. Yaseri and P. Ye and Henock G. Yebyo and P. Yip and N. Yonemoto and Seok-Jun Yoon and M. Younis and Chuanhua Yu and Z. Zaidi and M. Zaki and H. Zeeb and Maigeng Zhou and S. Zodpey and L. Zuhlke and C. Murray},
  journal={Lancet (London, England)},
  year={2016},
  volume={388},
  pages={1545 - 1602}
}
Background Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), we estimated the incidence, prevalence, and years lived with disability for diseases and injuries at… Expand

Paper Mentions

Interventional Clinical Trial
Mental health problems and overweight often co-occur, they have their origin in early childhood and new research evidence suggest a key role of cognitive, emotional and behavioral… Expand
ConditionsInfant Mental Health, Parent-Child Relations, Parenting
InterventionBehavioral
Interventional Clinical Trial
The present study has been designed to compare the efficacy and safety of augmentation of SSRIs with Amantadine vs Pramipexole vs the recommended Quetiapine augmentation in… Expand
ConditionsTreatment Resistant Depression
InterventionDrug
Interventional Clinical Trial
objectives: The primary aim of APIXBRAIN-HF Trial is to explore the effects of apixaban on brain protection in patients with sinus rhythm and heart failure Primary / Secondary… Expand
ConditionsCerebrovascular Disease, Heart Failure, Sinus Rhythm
InterventionDrug
Interventional Clinical Trial
The treatment of resistant depression should be optimized aiming at complete remission of symptoms, a complex condition due to several factors. Approximately 1/3 of patients with… Expand
ConditionsDepressive Disorder
InterventionDevice, Diagnostic Test, Drug, (+1 more)
Global, Regional, and National Prevalence, Incidence, and Disability-Adjusted Life Years for Oral Conditions for 195 Countries, 1990–2015: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors
  • N. Kassebaum, A.G.C. Smith, +6 authors G.Y. U. H. H. L. R. A. Y.S. Y.H. Y. G.A. R. A. P. M. C. Abyu Alsharif Asayesh Benzian Dandona Dandona Kasa
  • Medicine
  • Journal of dental research
  • 2017
TLDR
Great efforts and potentially different approaches are needed if the oral health goal of reducing the level of oral diseases and minimizing their impact is to be achieved by 2020, despite some challenges with current measurement methodologies for oral diseases. Expand
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
TLDR
The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016 and updated the Socio-demographic Index. Expand
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
TLDR
The GBD study provides annual updates on estimates of deaths, prevalence, and disability-adjusted life years (DALYs), a summary measure of fatal and non-fatal disease outcomes, for over 300 diseases and injuries, for 188 countries from 1990 to the most recent year. Expand
Incidence, prevalence, mortality, disability-adjusted life years and risk factors of cancer in Australia and comparison with OECD countries, 1990-2015: findings from the Global Burden of Disease Study 2015.
TLDR
The incidence of cancer has increased over 25 years, and behavioral risks are responsible for a large proportion of cancer deaths, and scaling up of prevention, early detection, and treatment of cancer is required to effectively address this growing health challenge. Expand
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015
TLDR
LRI remains a largely preventable disease and cause of death, and continued efforts to decrease indoor and ambient air pollution, improve childhood nutrition, and scale up the use of the pneumococcal conjugate vaccine in children and adults will be essential in reducing the global burden of LRI. Expand
Population health and regional variations of disease burden in Japan, 1990–2015: a systematic subnational analysis for the Global Burden of Disease Study 2015
TLDR
Japan has entered the era of super-ageing and advanced health transition, which is increasingly putting pressure on the sustainability of its health system, and the potential sources of regional variations, including subnational health system performance, urgently need assessment. Expand
Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study
TLDR
If current trends in tuberculosis incidence continue, few countries are likely to meet the SDG target to end the tuberculosis epidemic by 2030, and several regions had higher rates of age-standardised incidence and mortality than expected on the basis of their SDI levels in 2016. Expand
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
TLDR
Non-communicable diseases comprised the greatest fraction of deaths, contributing to 73·4% (95% uncertainty interval [UI] 72·5–74·1) of total deaths in 2017, while communicable, maternal, neonatal, and nutritional causes accounted for 18·6% (17·9–19·6), and injuries 8·0% (7·7–8·2). Expand
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
TLDR
The Global Burden of Disease 2016 Study provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016, and evaluation of the expected epidemiological transition with changes in development and where local patterns deviate from these trends is evaluated. Expand
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
TLDR
DALYs and HALE and their relationship to SDI represents a robust framework on which to benchmark geography-specific health performance and SDG progress and supports continued efforts to elevate personal income, improve education, and limit fertility. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 155 REFERENCES
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
TLDR
The results can guide future health initiatives through examination of epidemiological trends and a better understanding of variation across countries. Expand
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
TLDR
Prevalence and severity of health loss were weakly correlated and age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010, but population growth and ageing have increased YLD numbers and crude rates over the past two decades. Expand
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
TLDR
The Global Burden of Disease Study 2013 estimated yearly deaths for 188 countries between 1990, and 2013 and computed two measures of convergence (inequality) across countries: the average relative difference across all pairs of countries (Gini coefficient) and the average absolute difference across countries. Expand
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
TLDR
The Global Burden of Disease 2015 Study provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015, finding several countries in sub-Saharan Africa had very large gains in life expectancy, rebounding from an era of exceedingly high loss of life due to HIV/AIDS. Expand
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
TLDR
The Global Burden of Disease Study 2013 estimated yearly deaths for 188 countries between 1990, and 2013 and computed two measures of convergence (inequality) across countries: the average relative difference across all pairs of countries (Gini coefficient) and the average absolute difference across countries. Expand
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
TLDR
Patterns of the epidemiological transition with a composite indicator of sociodemographic status, which was constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population, were quantified. Expand
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
TLDR
The comparative risk assessment framework developed for previous iterations of the Global Burden of Disease Study 2015 was used to estimate attributable deaths, disability-adjusted life-years (DALYs), and trends in exposure by age group, sex, year, and geography for 79 behavioural, environmental and occupational risks or clusters of risks from 1990 to 2015. Expand
The burden of disease in older people and implications for health policy and practice
23% of the total global burden of disease is attributable to disorders in people aged 60 years and older. Although the proportion of the burden arising from older people (≥60 years) is highest inExpand
Burden of disease due to dementia in the elderly population of Korea: present and future
TLDR
Dementia has the highest burden of disease in the elderly Korean population, and this burden will increase sharply with the aging of the population, by applying demographic structure projections in terms of 5-year age groups in Korea from 2010 to 2050. Expand
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
TLDR
Age-standardised adult diabetes prevalence in 2014 was lowest in northwestern Europe, and highest in Polynesia and Micronesia, at nearly 25%, followed by Melanesia and the Middle East and north Africa. Expand
...
1
2
3
4
5
...